Grifols Egypt Collaborates with Orange Business to Deliver New Data Center and Communications Infrastructure, Supporting Advanced Medical Processes
September 11 2024 - 4:00AM
Business Wire
- Grifols Egypt is leading the national goal to achieve
self-sufficiency in vital lifesaving plasma derivatives and create
a fully integrated plasma platform
- Orange Business leverages its local expertise and service
center to provide co-location services, building on its
relationship with ACUD (Administrative Capital for Urban
Development) data center
Orange Business is pleased to announce the successful completion
of the first phase of a new data center and communications
infrastructure for Grifols Egypt for its Plasma Derivatives (GEPD)
facility in the Medical City within the New Administrative
Capital.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240911024211/en/
Grifols Egypt is leading the national
goal to achieve self-sufficiency in vital lifesaving plasma
derivatives and create a fully integrated plasma platform (Photo
credit: Orange Business Services)
The partnership involves delivering co-location services through
the ACUD (Administrative Capital for Urban Development) commercial
and telco data center. This includes communication services,
support in equipment procurement, and professional services during
the project build-up and upcoming operations.
Grifols Egypt for Plasma Derivatives (GEPD) is a joint venture
between Egypt’s National Service Projects Organization (NSPO) and
Grifols, a global healthcare company. Via this National Project,
the pioneering company sets the roadmap for a more robust Egyptian
healthcare system aiming to achieve self-sufficiency in
plasma-derived medicines. This strategic project will guarantee a
sustainable supply of essential therapeutics that are used as
treatments for life-threatening diseases.
Orange Business is supporting Grifols Egypt in the critical set
up of the project. With its global experience and over 25 years of
operations in Egypt, coupled with its technical and system
integration expertise, Orange Business possesses a comprehensive
understanding of the regulatory and legal requirements essential
for the project's success.
ACUD’s data center boasts an advanced infrastructure featuring
state-of-the-art technology to meet the needs of businesses, from
co-location services for dedicated server hosting to cloud hosting
options. The data center is DBO (design, build and operate)
certified.
Kristof Symons, CEO International at Orange Business commented:
“We are delighted to put our experience at the service of this
vital national health project in Egypt, and to contribute to its
implementation and operations. This ambitious project empowered by
Grifols Egypt for Plasma Derivatives (GEPD) should be an example of
how private and government institutions are in the best position to
enable fundamental changes for a country. Our technical skills,
experienced resources, and global knowledge were pivotal in
enabling Grifols to replicate its global business model in Egypt.
This project shows how Orange Business can support its customers in
creating a positive impact in today’s society.”
Dr. Ahmed Serag, Chief Strategy and Projects Officer in GEPD
commented: "We are glad to announce this successful collaboration
with Orange Business. This achievement enhances the GEPD strategy
that prioritizes utilizing cutting edge technologies while ensuring
a positive impact on the industry, economy and most importantly the
quality of life for Egyptian patients.
"Grifols Egypt WAN will interconnect critical facilities,
including a plasma laboratory, co-location data center, plasma
warehouse, 20 plasma donation centers, and a state-of-the-art
manufacturing facility. This comprehensive network infrastructure
will ensure efficient operations and the timely delivery of
plasma-derived medicines to patients in need,” added Dr. Serag.
Khaled Abbas, ACUD’s Chairman and Managing Director, praised the
collaboration with Orange Business and the ongoing development of
Egypt’s communication infrastructure and healthcare systems, which
is set to benefit medical centers across the country, including the
Medical City. He emphasized ACUD’s role in developing one of the
Middle East’s leading regional data centers, integral to the
Digital Egypt Strategy, and serving all New Administrative Capital
(NAC) clients.
About Orange Business Orange Business, the enterprise
division of the Orange Group, is a leading network and digital
integrator, supporting customers to create positive impact and
digital business. The combined strength of its next-generation
connectivity, cloud, and cybersecurity expertise, platforms, and
partners provides the foundation for enterprises around the world.
With 30,000 employees across 65 countries, Orange Business enables
its customers’ transformations by orchestrating end-to-end secured
digital infrastructure and focusing on the employee, customer, and
operational experience. More than 30,000 B-to-B customers put their
trust in Orange Business globally.
Orange is one of the world’s leading telecommunications
operators with revenues of 39.7 billion euros in 2023 and 285
million customers worldwide at 30 June 2024. The Group is present
in 26 countries (including non-consolidated countries). In February
2023, the Group presented its strategic plan "Lead the Future",
built on a new business model and guided by responsibility and
efficiency. "Lead the Future" capitalizes on network excellence to
reinforce Orange's leadership in service quality.
Orange is listed on the Euronext Paris (ORA) and on the New York
Stock Exchange (ORAN). For more information:
www.orange-business.com or follow us on LinkedIn and on X:
@orangebusiness Orange and any other Orange product or service
names included in this material are trademarks of Orange or Orange
Brand Services Limited.
About Grifols Egypt for Plasma Derivatives Grifols Egypt
for Plasma Derivatives (GEPD) is a joint-venture company between
Egypt’s National Service Projects Organization and Grifols. The
strategic partnership’s combined expertise, technology and
resources seeks to strengthen Egypt’s healthcare system through
achieving self-sufficiency in plasma-derived medicines while
reinforcing Grifols’ international expansion in the Middle East and
Africa.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240911024211/en/
Press: Emmanuelle Nahmany, Orange Business,
emmanuelle.nahmany@orange.com
Press: Wafia Al Badry, Grifols Egypt for Plasma
Derivatives (GEPD), wafia.elbadry@grifolsegyptplasma.com
Ormat Technologies (NYSE:ORA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ormat Technologies (NYSE:ORA)
Historical Stock Chart
From Sep 2023 to Sep 2024